Active surveillance may be recommended if you are not having symptoms and your oncologist finds no indications for treatment.
Our radiation oncologists design an individualized plan to target the tumor to kill or slow the growth of cancer cells.
Targeted therapies block the growth of cancer cells or interfere with processes that help cancer cells survive. Many targeted therapies are taken orally; how often they are taken can vary. Monoclonal antibody therapy is a targeted therapy that is administered through an IV, by itself or in combination with other targeted therapies or chemotherapy.
Systemic chemotherapy is administered via oral medication, by infusion into a vein, or by injection.
A stem cell or bone marrow transplant replaces lymphoma cells with healthy blood cells.
CAR T-Cell Therapy for Advanced Non-Hodgkin Lymphoma
We are an authorized treatment center for two FDA-approved CAR T-cell therapies (brand names: Yescarta and Kymriah) for the treatment of certain advanced non-Hodgkin lymphomas. People with advanced non-Hodgkin lymphoma who have failed at least two lines of systemic treatment may be candidates for this one-time treatment.